- Home
- NCNA
NCNA
NuCana plc
as 11-15-2024 4:00pm EST
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
| Founded: | 1997 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.4M | IPO Year: | 2017 |
| Target Price: | $25.00 | AVG Volume (30 days): | 138.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -16.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.49 - $19.40 | Next Earning Date: | 11-26-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest NuCana plc News
NCNA Breaking Stock News: Dive into NCNA Ticker-Specific Updates for Smart Investing
MT Newswires
7 days ago
NuCana Reports 'Encouraging' Data From Study to Treat Patients With Lung Cancer
GlobeNewswire
7 days ago
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
GuruFocus.com
a month ago
Baillie Gifford's Strategic Acquisition of NuCana PLC Shares
GlobeNewswire
2 months ago
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
Zacks
2 months ago
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study
MT Newswires
2 months ago
Sector Update: Health Care Stocks Higher Late Afternoon
MT Newswires
2 months ago
Top Midday Gainers
Benzinga
2 months ago
NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Compare NCNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NCNA NuCana plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.